+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Acute Heart Failure Global Clinical Trials Review, H2, 2019

  • ID: 4655582
  • Clinical Trials
  • December 2019
  • Region: Global
  • 181 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen Inc
  • Bristol-Myers Squibb Co
  • Capricor Therapeutics Inc
  • Cardiorentis AG
  • Celerion Inc
  • MORE
Acute Heart Failure Global Clinical Trials Review, H2, 2019

Summary

The clinical trial report, “Acute Heart Failure Global Clinical Trials Review, H2, 2019“ provides an overview of Acute Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using the proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen Inc
  • Bristol-Myers Squibb Co
  • Capricor Therapeutics Inc
  • Cardiorentis AG
  • Celerion Inc
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Acute Heart Failure Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Acute Heart Failure
  • Nov 17, 2019: Interim analysis from EMPRISE real-world study shows empagliflozin decreased risk of hospitalisation for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists
  • Nov 13, 2019: Lilly and Boehringer begin study of Jardiance in heart failure
  • Oct 25, 2019: Windtree Therapeutics provides business update on istaroxime
  • Clinical Trial Profile Snapshots
Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About the Author
  • Contact Us
  • Source
List of Tables
  • Acute Heart Failure Therapeutics, Global, Clinical Trials by Region, 2019*
  • Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019*
  • Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2019*
  • Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2019*
  • Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2019*
  • Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
  • Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
List of Figures
  • Acute Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019*
  • Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2019*
  • Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2019*
  • Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2019*
  • Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
  • Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
  • Methodology
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Novartis AG
  • Cytokinetics Inc
  • Capricor Therapeutics Inc
  • Abbott Laboratories
  • Bristol-Myers Squibb Co
  • Cardiorentis AG
  • Celerion Inc
  • Otsuka Holdings Co Ltd
  • Theravance Biopharma Inc
  • Amgen Inc
Note: Product cover images may vary from those shown
Adroll
adroll